Tylenol PM diphenhydramine overview:
- Who: A Tylenol PM user is suing Johnson & Johnson.
- Why: The plaintiff says the company falsely labels the product as “non-habit-forming.”
- Where: The Tylenol PM class action was filed in a California federal court.
A Tylenol PM user is suing Johnson & Johnson claiming the company falsely labels the product as non-habit-forming.
Plaintiff Sirreon Goodson filed the Tylenol PM diphenhydramine class action complaint against Johnson & Johnson Services Inc. on Nov. 13 in a California federal court, alleging violations of state and federal consumer laws.
The California man claims Johnson & Johnson’s Tylenol PM sleep aid falsely promises to be non-habit-forming despite containing diphenhydramine, a substance known for its potential to cause dependency.
The sleep aid market, valued at nearly $65 billion globally, continues to expand as Americans grapple with chronic sleeplessness, Goodson claims.
According to the American Academy of Sleep Medicine, 22% of U.S. adults use sleep aid products, a reflection of increasing sleep issues among the population, the Tylenol PM class action claims.
Tylenol PM users can become dependent, lawsuit claims
Tylenol PM, like other sleep aids, contains diphenhydramine, an antihistamine first marketed in 1946 under the brand Benadryl, Goodson states. While it is widely used for its sedative effects, the Tylenol PM diphenhydramine lawsuit claims that frequent use can lead to tolerance, requiring higher doses, and, ultimately, dependency.
Goodson alleges that he himself developed a habit after using the product, contrary to the label’s assurances. He alleges he purchased Tylenol PM multiple times in late 2023, trusting the “non-habit-forming” claim prominently displayed on the packaging.
He also alleges that he paid a price premium for a product he believed was safe and without the risk of dependency.
“[Consumers] prefer and desire sleep aid products that do not cause habitual use,” the lawsuit states, while accusing Johnson & Johnson of profiting from consumer trust by misleadingly marketing Tylenol PM as a safe sleep aid.
As a result, Goodson is looking to represent anyone in the United States who bought Tylenol PM. He’s suing for breach of warranty and state consumer laws and seeking certification of the class action, damages, fees, costs and a jury trial.
Meanwhile, the makers of Tylenol Cold and Flu Severe and Mucinex Sinus Max are facing a class action lawsuit related to the ineffectiveness of the active ingredient phenylephrine in their over-the-counter products.
What do you think of the allegations in the Tylenol PM class action? Let us know in the comments.
The plaintiff is represented by Timothy Fisher and Brittany S. Scott of Bursor & Fisher P.A.
The Tylenol PM class action is Sirreon Goodson v. Johnson & Johnson Services Inc., Case No. 2:24-at-01432 in the U.S. District Court for the Eastern District of California.
Don’t Miss Out!
Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!
Read About More Class Action Lawsuits & Class Action Settlements:
506 thoughts onTylenol PM contains habit-forming diphenhydramine, class action claims
I qualify for all the Tylenol settlements
They messed up my mom’s liver. She is now deceased because she took them everyday.